About Careers MedBlog Contact us

France Bans Breast Implants Linked to Rare Cancer

by Hannah Joy on April 6, 2019 at 11:41 AM
Font : A-A+

France Bans Breast Implants Linked to Rare Cancer

For the first time, France has banned a type of breast implant linked to a rare form of cancer that attacks the immune system, reported the media.

The ban covers several models of the implants with a textured surface, which are produced by six manufacturers, the BBC reported. Those implants have been linked to a type of cancer that attacks the immune system.


The National Agency for Medicines and Health Products (ANSM) said in a statement that the ban was a "precautionary measure" taken in light of the "rare but serious danger" posed by the implants.

According to the report, some 70,000 women are believed to have received these implants, out of an estimated 400,000 women who have had breast implants in France.

It said it had recorded 59 cases of the cancer among French implant wearers, of whom three had died.

"The more the implant is textured and rough the greater the risk of BIA-ALCL (anaplastic large-cell lymphoma)," the ANSM said, adding it had noted a "significant increase in cases of anaplastic large-cell lymphoma linked to the wearing of breast implants since 2011".

The ANSM, however, did not recommend that the women who had received the implants undergo surgery to have them removed, because of the "rarity of the risk", the report said.

Canada also said on Thursday it aimed to suspend the same type of implant as a "precautionary measure" following a safety review triggered by an increase in cases of BIA-ALCL.

Jean-Claude Mas, the founder of Poly Implant Prothese (PIP) French company, that was found to have used sub-standard silicone gel in its implants died on Thursday.

PIP created a popular brand of implant that was filled with a cheap industrial-grade silicone gel, rather than medical-grade silicone, resulting in implants rupturing. It exported 80 percent of its implants before the firm was shut down.

The scandal affected about 300,000 women in 65 countries, including France, the UK, Germany, Venezuela and Brazil.

Source: IANS


Recommended Reading

Latest Cancer News

Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
How Does New Drugs Work Together to Reduce Lung Tumors?
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.
New Combination Therapy Proves Effective Against Prostate Cancer
Combination treatment with TALZENNA and XTANDI was found to benefit prostate cancer patients, revealed study.
Can Vitamin A Rich Diet Help Reduce Pancreatitis Risk
In leukemia patients, reduced amounts of dietary vitamin A is associated with a higher risk and severity of pancreatitis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

France Bans Breast Implants Linked to Rare Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests